Modulation of immune function by morphine: implications for susceptibility to infection S Roy, J Wang, J Kelschenbach, L Koodie, J Martin Journal of Neuroimmune Pharmacology 1, 77-89, 2006 | 181 | 2006 |
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated … MT Nedelcovych, L Tenora, BH Kim, J Kelschenbach, W Chao, E Hadas, ... Journal of medicinal chemistry 60 (16), 7186-7198, 2017 | 68 | 2017 |
EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment CJ Gu, A Borjabad, E Hadas, J Kelschenbach, BH Kim, W Chao, ... PLoS pathogens 14 (6), e1007061, 2018 | 59 | 2018 |
Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV JL Kelschenbach, M Saini, E Hadas, C Gu, W Chao, G Bentsman, ... Journal of Neuroimmune Pharmacology 7 (2), 380-387, 2012 | 47 | 2012 |
Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses H He, LR Sharer, W Chao, CJ Gu, A Borjabad, E Hadas, J Kelschenbach, ... Journal of Neuropathology & Experimental Neurology 73 (1), 59-71, 2014 | 46 | 2014 |
Morphine withdrawal contributes to Th cell differentiation by biasing cells toward the Th2 lineage J Kelschenbach, RA Barke, S Roy The Journal of Immunology 175 (4), 2655-2665, 2005 | 43 | 2005 |
Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice BH Kim, J Kelschenbach, A Borjabad, E Hadas, H He, MJ Potash, ... Aids 33 (6), 973-984, 2019 | 42 | 2019 |
In vivo activation of a mutant μ-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of μ-receptor activation and δ-receptor blockade in … S Roy, X Guo, J Kelschenbach, Y Liu, HH Loh Journal of Neuroscience 25 (12), 3229-3233, 2005 | 35 | 2005 |
Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model A Omeragic, N Kara-Yacoubian, J Kelschenbach, C Sahin, CL Cummins, ... Scientific reports 9 (1), 9428, 2019 | 34 | 2019 |
Glutamine antagonist JHU083 normalizes aberrant glutamate production and cognitive deficits in the EcoHIV murine model of HIV-associated neurocognitive disorders MT Nedelcovych, BH Kim, X Zhu, LE Lovell, AA Manning, J Kelschenbach, ... Journal of Neuroimmune Pharmacology 14, 391-400, 2019 | 30 | 2019 |
Efficient expression of HIV in immunocompetent mouse brain reveals a novel nonneurotoxic viral function in hippocampal synaptodendritic injury and memory impairment J Kelschenbach, H He, BH Kim, A Borjabad, CJ Gu, W Chao, M Do, ... MBio 10 (4), 10.1128/mbio. 00591-19, 2019 | 30 | 2019 |
Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is … S Das, J Kelschenbach, R Charboneau, RA Barke, S Roy Journal of Biological Chemistry 286 (34), 29806-29817, 2011 | 24 | 2011 |
Morphine withdrawal inhibits IL-12 induction in a macrophage cell line through a mechanism that involves cAMP J Kelschenbach, J Ninkovic, J Wang, A Krishnan, R Charboneau, ... The Journal of Immunology 180 (6), 3670-3679, 2008 | 22 | 2008 |
Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment M Jaureguiberry-Bravo, J Kelschenbach, A Murphy, L Carvallo, E Hadas, ... Journal of Leucocyte Biology 109 (3), 675-681, 2021 | 10 | 2021 |
Prevention and treatment of HIV infection and cognitive disease in mice by innate immune responses B Dong, A Borjabad, J Kelschenbach, W Chao, DJ Volsky, MJ Potash Brain, behavior, & immunity-health 3, 100054, 2020 | 8 | 2020 |
CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice BH Kim, E Hadas, J Kelschenbach, W Chao, CJ Gu, MJ Potash, DJ Volsky Scientific Reports 13 (1), 6577, 2023 | 6 | 2023 |
Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI AJ Murphy, J Kelschenbach, H He, W Chao, BH Kim, DJ Volsky, ... Frontiers in immunology 13, 1004985, 2022 | 6 | 2022 |
Treatment of EcoHIV-infected Mice with Intranasal Insulin Abrogates Cognitive Impairment and Normalizes Energy Metabolite Alterations Associated with HAND BH Kim, J Alt, C Rojas, E Hadas, J Kelschenbach, A Borjabad, ... JOURNAL OF NEUROVIROLOGY 21, S36-S36, 2015 | 2 | 2015 |
Replication of chimeric HIV in mouse brain induces HAND-like pathology and cognitive disease independent of HIV envelope glycoprotein J Kelschenbach, A Borjabad, W Chao, CJ Gu, H He, G Bentsman, ... JOURNAL OF NEUROVIROLOGY 18, 53-54, 2012 | 2 | 2012 |
Protocol for optimizing production and quality control of infective EcoHIV virions HR Alfar, DN Pariser, H Chanzu, S Joshi, DM Coenen, J Lykins, ... STAR protocols 4 (3), 102368, 2023 | 1 | 2023 |